# rizatriptan benzoate

NDC: 68462-468
Generic name: rizatriptan benzoate
Labeler / Manufacturer: Glenmark Pharmaceuticals Inc., USA
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20130701

FDA application: ANDA201914

## Active ingredients

- RIZATRIPTAN BENZOATE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68462-468"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68462-468
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4de33a24-db69-444a-b04d-c69ccba57ab2